Cancer Research UK Cambridge Institute’s Post

Nanobombs: The Microscopic Cancer Destroyers!🦠💣 Scientists have unleashed a very high-impact weapon in the war on cancer: carbon nanotube "nanobombs"! 🎯💪 The University of Delaware researchers, led by Prof. Balaji Panchapakesan, are pioneering these microscopic marvels that can literally blow up breast cancer tumors! 🧪🔬 These tiny tech wonders are the result of two years of intense research, using carbon atoms arranged in tubular form to create precision cancer-fighting tools. 🏗️📏 While still in the early stages, the team's mission is crystal clear: "Make no mistake, we are focused on eradicating cancer." 💯 The future of medicine is here, and it's explosively small! 💥🔬🔮 Stay ahead with Saras AI Institute in the rapidly evolving field of artificial intelligence. Go from AI awareness to AI expertise. Learn how AI is made by visiting our website. 🔗 Website Link in the Bio! #SarasAIInstitute #NanoBombs #CancerResearch #Nanotechnology #MedicalBreakthrough #FightCancer #ScienceAdvancement #HealthInnovation

Some of you are still asking the question: "Why invest in space and not, for example, in cancer treatment?" What if investing in space IS an investment in cancer treatment? There are studies that indicate a connection between the effect of accelerated aging of cells in a state of microgravity and the multiplying effect of some types of cancer treatments. If so, then perhaps space is not only a direction for business development, but also - considering the increasing number of cancer cases globally - our destiny and salvation? https://lnkd.in/d2eQ9ikh

I'm thrilled to share that I have officially begun my PhD at the Università degli Studi di Firenze and LENS - European Laboratory for Non-linear Spectroscopy, under the guidance of Prof.Ludovico Silvestri My research will focus on "Tissue coloring with multiplexed hybridization for 3D molecular characterization of cancer tissue." This work is part of the 3DHIST project, an international research collaboration funded by the Swiss National Science Foundation SNSF. The main goal of the project is to push the boundaries of cancer research by developing advanced 3D imaging techniques to study colorectal cancer metastasis. By using innovative multimodal 2D and 3D imaging, we aim to gain deeper insights into how cancer spreads, particularly through the lymphatic system. #PhD #CancerResearch #3DHIST #MolecularOncology #3DImaging #LightSheetMicroscopy #Histopathology #ResearchCollaboration #LENS #UniversityofFlorence

🔍 Delighted to share that the paper "Attention-Map Augmentation for Hypercomplex Breast Cancer Classification" has been accepted by the journal Pattern Recognition Letters. 📝 This project, co-authored by Eleonora Lopez, Filippo Betello, Eleonora Grassucci, Danilo Comminiello and myself, is a culmination of a study started exploiting a novel work on a patch-based CNN conducted during my academic life at Sapienza University of Rome. Breast cancer detection holds immense importance, and the framework explored, focusing on attention maps and hypercomplex neural networks, presents a solution that surpasses existing methods, particularly in discerning malignant from benign masses in mammography and histopathological images. This achievement is a way to show the importance of advancing healthcare through cutting-edge research. 📚💡 ArXiv: https://lnkd.in/dyyhrKhz #PatternRecognition #BreastCancer #DeepLearning #Research #Sapienza

Joining the spatial biology congress in The Hague on July 11-12?   Be sure to explore poster #10 at the Spatial Biology Congress!   We will present the HOST-Factor, an innovative approach developed by Janusz F., Edna (Eti) Cukierman, et al. at Fox Chase Cancer Center. The study combines automated cycling highplex immunofluorescent microscopy (COMET, Lunaphore) with artificial intelligence (AI)-guided image analysis #Phenoplex, offering new insights into the complexities of cancer biology and the tumor microenvironment.   "Visiopharm's Phenoplex workflow allowed me, as a cancer biologist, to effectively scrutinize high-plex immunofluorescence images of pancreatic cancer, investigating a large panel of markers and uncovering the spatial relationships of cell populations, despite being a naive user. This user-friendly platform bridges the gap between basic and translational research, representing the future of cancer cell biology." - Janusz Franco-Barraza, MD, PhD.   See you there! #SpatialBiology

Hey Fam!! Recently presented my research paper titled "Leveraging Convolutional Neural Networks and Multimodal Imaging Data for Accurate and Early Lung Cancer Screening" at the 6th International Conference on Inventive Computation and Information Technologies (ICICIT 2024) held during 16-17 April 2024 at Stamford International University,Bangkok, Thailand. The paper detailed the development and performance of a novel AI-powered tool for rapid and accurate lung cancer screening from CT scans. The work was well-received by the panel of leading oncologists and medical imaging experts in attendance.#LungCancer, #MedicalImaging, #ArtificialIntelligence #ConferencePresentation #Research

🔬Cancer biology remains a vastly complex field, but the discoveries made during this research work can be considered a cornerstone for the emerging field of cancer neuroscience, as well as suggesting specific avenues for treatment. 🎤 Thomas Kuner, senior co-author, highlighted that “this is a field that is just at the beginning. I'm pretty sure we will find many new types of interactions (between neurons and cancer cells) and will also find ways of interfering with these interactions. So I think that this (research work) is a real game changer”. Heidelberg University #BIALFoundation30Years #Biomedicine #BIALAward #FundaçãoBIAL #BIALAwardinBiomedicine

129 years ago today, x-rays were discovered for the first time, a date immortalized as #WorldRadiographyDay. Ever since, radiation has become an integral part of biomedical research, from the x-ray crystallography that enabled the discovery of DNA’s structure to the precision radiation therapies that play a critical role in the fight against cancer. At The Wistar Institute, our Imaging Facility offers the latest in radiation-based imaging, which allows researchers to more effectively analyze the progression of cancer – a critical step in stopping it. #radiography #radiation #xray #sciencehistory

🚨Exciting News from the University Hospital of Technical University Munich!🚨 We are thrilled to welcome the next generation of optical in-vivo imaging at the Central Institute for Translational Cancer Research (“TranslaTUM”) with the arrival of the LAGO by Spectral Instruments Imaging. This cutting-edge system offers unparalleled sensitivity, LED illumination, and the ability to image up to 10 mice simultaneously—a true game changer for translational cancer research. 🎯 Obtained through a DFG large equipment grant to Prof. S. Kossatz and co-applicants, and co-financed by the TranslaTUM (https://lnkd.in/ec4hjmpA), TUM University Hospital researchers and collaborators will be leveraging this advanced technology to drive forward their innovative cancer research projects. The LAGO represents a huge step in improving imaging precision and enhancing research outcomes in the fight against cancer. Curious, would like to learn more about the latest developments in in-vivo imaging, please contact us! 🧬🔬 https://lnkd.in/egHXYm7C #CancerResearch #OpticalImaging #TranslaTUM #TranslationalResearch #InnovationInScience#InVivoImaging #preclinicalresearch

🔈 LISTEN: Dr. Chunzhang Yang of our Neuro-Oncology Branch was interviewed on "Neuro-Oncology: The Podcast" about his recent work in enhancing chemotherapy to control glioblastoma cell growth. National Cancer Institute (NCI), Society for Neuro-Oncology 🎙 : https://lnkd.in/etbMqFgZ Dr. Chunzhang Yang studies the genetic and molecular basis of brain tumors and leads the Molecular and Cell Biology Research Program at the Neuro-Oncology Branch (NOB). The goal of his research is to understand the vulnerabilities of brain tumors and identify biological signatures—which can be used to generate experimental therapeutics that improve the current standard of care for patients. #CancerResearch #NeuroOncology #Podcast #Innovation